Inventage Lab (XKRX:389470) Accounts Payable & Accrued Expense : ₩0.0 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Inventage Lab Accounts Payable & Accrued Expense?

Inventage Lab's quarterly accounts payable & accrued expense increased from Sep. 2023 (₩1,027.8 Mil) to Dec. 2023 (₩1,763.0 Mil) but then declined from Dec. 2023 (₩1,763.0 Mil) to Mar. 2024 (₩0.0 Mil).

Inventage Lab's annual accounts payable & accrued expense increased from Dec. 2021 (₩688.7 Mil) to Dec. 2022 (₩1,307.5 Mil) and increased from Dec. 2022 (₩1,307.5 Mil) to Dec. 2023 (₩1,763.0 Mil).

Inventage Lab Accounts Payable & Accrued Expense Historical Data

The historical data trend for Inventage Lab's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inventage Lab Accounts Payable & Accrued Expense Chart

Inventage Lab Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

372.00

425.71

688.68

1,307.49

1,762.97

Inventage Lab Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial					741.86	1,317.83	1,027.84	1,762.97	-

Inventage Lab Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Inventage Lab (XKRX:389470) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Inventage Lab Inc (XKRX:389470) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

N/A

Address

24, Dunchon-daero 388 beon-gil, 612, Woolim Lions Valley 3, Jungwon-gu, Gyeonggi-do, Seongnam-si, KOR, 13403

Website

https://www.inventagelab.com

Inventage Lab Inc operates medical technology development businesses. It engages in the development of an innovative Drug Delivery System (DDS). It has developed Laminar FluiDigm, a microfluidics-based novel platform technology that builds the foundation for IVL- DrugFluidic and IVL-GeneFluidic, which are specific platform technologies used for developing and manufacturing long-acting injectables and gene-delivery therapeutics.

Inventage Lab (XKRX:389470) Headlines

No Headlines